Early Access Program for ALXN1840 in Patients With Wilson Disease

NCT05686564 · clinicaltrials.gov ↗

NO_LONGER_AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Wilson Disease

Interventions

DRUG: ALXN1840

Sponsor

Alexion Pharmaceuticals, Inc.